Expression of GIV/Girdin, a metastasis-related protein, predicts patient survival in colon cancer

FASEB Journal

Volumn 25, Issue 2, 2011, Pages 590-599

  Garcia Marcos, Mikel ^a   Jung, Barbara H ^b,d   Ear, Jason ^b   Cabrera, Betty ^b   Carethers, John M ^b,c,d   Ghosh, Pradipta ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Cell migration; Cytoskeleton; G protein; Growth factor receptors; Guanine nucleotide exchange factor; Microsatellite instability; PI3K Akt

Indexed keywords

CALVASCULIN; GIRDIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MICROSATELLITE DNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR CELL;

CARCINOMA; CELL LINE, TUMOR; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MICROFILAMENT PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VESICULAR TRANSPORT PROTEINS;

GREAT ISLAND VIRUS;

EID: 79551648550     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-167304     Document Type: Article

References (44)

1. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verástegui, E., and Zlotnik, A. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-56
2. Larue, L., and Bellacosa, A. (2005) Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene 24, 7443-7454
3. Qiao, M., Iglehart, J. D., and Pardee, A. B. (2007) Metastatic potential of 21T human breast cancer cells depends on Akt/ protein kinase B activation. Cancer Res. 67, 5293-5299
4. Fidler, I. J. (2003) The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nat. Rev. Cancer 3, 453-458
5. Qiao, M., Sheng, S., and Pardee, A. B. (2008) Metastasis and AKT activation. Cell Cycle 7, 2991-2996
6. Garcia-Marcos, M., Ghosh, P., and Farquhar, M. G. (2009) GIV is a nonreceptor GEF for G alpha i with a unique motif that regulates Akt signaling. Proc. Natl. Acad. Sci. U. S. A. 106, 3178-3183
7. Garcia-Marcos, M., Ghosh, P., Ear, J., and Farquhar, M. G. A structural determinant that renders Gαi sensitive to activation by GIV/Girdin is required to promote cell migration. J. Biol. Chem. 285, 12765-12777
8. Enomoto, A., Murakami, H., Asai, N., Morone, N., Watanabe, T., Kawai, K., Murakumo, Y., Usukura, J., Kaibuchi, K., and Takahashi, M. (2005) Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev. Cell 9, 389-402
9. Ghosh, P., Garcia-Marcos, M., Bornheimer, S. J., and Farquhar, M. G. (2008) Activation of Galphai3 triggers cell migration via regulation of GIV. J. Cell Biol. 182, 381-393
10. Jiang, P., Enomoto, A., Jijiwa, M., Kato, T., Hasegawa, T., Ishida, M., Sato, T., Asai, N., Murakumo, Y., and Takahashi, M. (2008) An actin-binding protein Girdin regulates the motility of breast cancer cells. Cancer Res. 68, 1310-1318
11. Kitamura, T., Asai, N., Enomoto, A., Maeda, K., Kato, T., Ishida, M., Jiang, P., Watanabe, T., Usukura, J., Kondo, T., Costantini, F., Murohara, T., and Takahashi, M. (2008) Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat. Cell Biol. 10, 329-337
12. Anai, M., Shojima, N., Katagiri, H., Ogihara, T., Sakoda, H., Onishi, Y., Ono, H., Fujishiro, M., Fukushima, Y., Horike, N., Viana, A., Kikuchi, M., Noguchi, N., Takahashi, S., Takata, K., Oka, Y., Uchijima, Y., Kurihara, H., and Asano, T. (2005) A novel protein kinase B (PKB)/AKT-binding protein enhances PKB kinase activity and regulates DNA synthesis. J. Biol. Chem. 280, 18525-18535
13. Ghosh, P., Beas, A., Bornheimer, S. J., Garcia-Marcos, M., Ear, J., Forry, E. P., Johannson, C. J., Jung, B., Cabrera, B. L., Carethers, J. M., and Farquhar, M. G. (2010) A Gi-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate. Mol. Biol. Cell. 21, 2338-2354
14. Enomoto, A., Ping, J., and Takahashi, M. (2006) Girdin, a novel actin-binding protein, and its family of proteins possess versatile functions in the Akt and Wnt signaling pathways. Ann. N. Y. Acad. Sci. 1086, 169-184
15. Weng, L., Enomoto, A., Ishida-Takagishi, M., Asai, N., and Takahashi, M. Girding for migratory cues: roles of the Akt substrate Girdin in cancer progression and angiogenesis. Cancer Sci. 101, 836-842
16. Band, V., Zajchowski, D., Swisshelm, K., Trask, D., Kulesa, V., Cohen, C., Connolly, J., and Sager, R. (1990) Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res. 50, 7351-7357
17. Bresalier, R. S., Hujanen, E. S., Raper, S. E., Roll, F. J., Itzkowitz, S. H., Martin, G. R., and Kim, Y. S. (1987) An animal model for colon cancer metastasis: establishment and characterization of murine cell lines with enhanced liver-metastasizing ability. Cancer Res. 47, 1398-1406
18. Grzesiak, J. J., and Bouvet, M. (2006) The alpha2beta1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines. Br. J. Cancer 94, 1311-1319
19. Vezeridis, M. P., Meitner, P. A., Tibbetts, L. M., Doremus, C. M., Tzanakakis, G., and Calabresi, P. (1990) Heterogeneity of potential for hematogenous metastasis in a human pancreatic carcinoma. J. Surg. Res. 48, 51-55
20. Jung, B., Doctolero, R. T., Tajima, A., Nguyen, A. K., Keku, T., Sandler, R. S., and Carethers, J. M. (2004) Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers. Gastroenterology 126, 654-659
21. Jung, B., Smith, E. J., Doctolero, R. T., Gervaz, P., Alonso, J. C., Miyai, K., Keku, T., Sandler, R. S., and Carethers, J. M. (2006) Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers. Int. J. Cancer 118, 2509-2513
22. Carethers, J. M., Hawn, M. T., Greenson, J. K., Hitchcock, C. L., and Boland, C. R. (1998) Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer. Gastroenterology 114, 1188-1195
23. Gervaz, P., Cerottini, J. P., Bouzourene, H., Hahnloser, D., Doan, C. L., Benhattar, J., Chaubert, P., Secic, M., Gillet, M., and Carethers, J. M. (2002) Comparison of microsatellite instability and chromosomal instability in predicting survival of patients with T3N0 colorectal cancer. Surgery 131, 190-197
24. Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodriguez-Bigas, M. A., Fodde, R., Ranzani, G. N., and Srivastava, S. (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58, 5248-5257
25. Talmadge, J. E. (2007) Clonal selection of metastasis within the life history of a tumor. Cancer Res. 67, 11471-11475
26. Duffy, M. J., van Dalen, A., Haglund, C., Hansson, L., Holinski- Feder, E., Klapdor, R., Lamerz, R., Peltomaki, P., Sturgeon, C., and Topolcan, O. (2007) Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur. J. Cancer 43, 1348-1360
27. IMPACT-B2 (1999) Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) J. Clin. Oncol. 17, 1356-1363
28. Gryfe, R., Kim, H., Hsieh, E. T., Aronson, M. D., Holowaty, E. J., Bull, S. B., Redston, M., and Gallinger, S. (2000) Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N. Engl. J. Med. 342, 69-77
29. Li, H., Fan, X., and Houghton, J. (2007) Tumor microenvironment: the role of the tumor stroma in cancer. J. Cell. Biochem. 101, 805-815
30. Saglam, O., Garrett, C. R., Boulware, D., Sayegh, Z., Shibata, D., Malafa, M., Yeatman, T., Cheng, J. Q., Sebti, S., and Coppola, D. (2007) Activation of the serine/threonine protein kinase AKT during the progression of colorectal neoplasia. Clin. Colorectal Cancer 6, 652-656
31. Noh, D. Y., Lee, Y. H., Kim, S. S., Kim, Y. I., Ryu, S. H., Suh, P. G., and Park, J. G. (1994) Elevated content of phospholipase C-gamma 1 in colorectal cancer tissues. Cancer 73, 36-41
32. Walther, A., Houlston, R., and Tomlinson, I. (2008) Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 57, 941-950
33. Popat, S., Hubner, R., and Houlston, R. S. (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J. Clin. Oncol. 23, 609-618
34. Esteller, M. (2007) Novel Tumour Suppressor, World Intellectual Property Organization (http://www.wipo.int) WO/2007/122369
35. Miller, L. (2006) U.S. Patent 20060074565 and World Intellectual Property Organization WO/2007/122369 and WO/2007/013671
36. Landis, C. A., Masters, S. B., Spada, A., Pace, A. M., Bourne, H. R., and Vallar, L. (1989) GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340, 692-696
37. Lyons, J., Landis, C. A., Harsh, G., Vallar, L., Grunewald, K., Feichtinger, H., Duh, Q. Y., Clark, O. H., Kawasaki, E., Bourne, H. R., and McCormick, F. (1990) Two G protein oncogenes in human endocrine tumors. Science 249, 655-659
38. Kan, Z., Jaiswal, B. S., Stinson, J., Janakiraman, V., Bhatt, D., Stern, H. M., Yue, P., Haverty, P. M., Bourgon, R., Zheng, J., Moorhead, M., Chaudhuri, S., Tomsho, L. P., Peters, B. A., Pujara, K., Cordes, S., Davis, D. P., Carlton, V. E., Yuan, W., Li, L., Wang, W., Eigenbrot, C., Kaminker, J. S., Eberhard, D. A., Waring, P., Schuster, S. C., Modrusan, Z., Zhang, Z., Stokoe, D., de Sauvage, F. J., Faham, M., and Seshagiri, S. (2010) Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466, 869-873
39. Van Raamsdonk, C. D., Bezrookove, V., Green, G., Bauer, J., Gaugler, L., O'Brien, J. M., Simpson, E. M., Barsh, G. S., and Bastian, B. C. (2009) Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457, 599-602
40. Garcia-Marcos, M., Ghosh, P., Ear, J., and Farquhar, M. G. (2010) A structural determinant that renders G alpha(i) sensitive to activation by GIV/girdin is required to promote cell migration. J. Biol. Chem. 285, 12765-12777
41. Simpson, F., Martin, S., Evans, T. M., Kerr, M., James, D. E., Parton, R. G., Teasdale, R. D., and Wicking, C. (2005) A novel hook-related protein family and the characterization of hook-related protein 1. Traffic 6, 442-458
42. Le-Niculescu, H., Niesman, I., Fischer, T., DeVries, L., and Farquhar, M. G. (2005) Identification and characterization of GIV, a novel Galpha i/s-interacting protein found on COPI, endoplasmic reticulum-Golgi transport vesicles. J. Biol. Chem. 280, 22012-22020
43. Flatmark, K., Maelandsmo, G. M., Martinsen, M., Rasmussen, H., and Fodstad, O. (2004) Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur. J. Cancer 40, 1593-1598
44. Thompson, E. W., Paik, S., Brunner, N., Sommers, C. L., Zugmaier, G., Clarke, R., Shima, T. B., Torri, J., Donahue, S., Lippman, M. E., Martin, G. R., and Dickson, R. B. (1992) Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J. Cell. Physiol. 150, 534-544